PXH ETF Analysis: FTSE RAFI Emerging Markets | NYSE
Diversified Emerging Mkts | NYSE, USA | Market Cap: 2.070m USD | 12M Return: 23.3% | US46138E7278 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.33M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Invesco FTSE RAFI Emerging Markets ETF (PXH) is an exchange-traded fund that seeks to track the performance of the FTSE RAFI Emerging Markets Index, which comprises approximately 350 common stocks of the largest companies located in countries classified as emerging markets by FTSE. The fund invests at least 90% of its total assets in the securities that make up the underlying index, as well as in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) that represent those index constituents.
As a passively managed fund listed on the NYSE, PXH provides investors with diversified exposure to large-cap emerging market equities through both direct securities and depositary receipts, which are financial instruments that allow U.S. investors to hold shares of foreign companies traded on domestic exchanges. The RAFI (Research Affiliates Fundamental Index) methodology used by the underlying index is notable for selecting and weighting constituents based on fundamental measures of company size-such as sales, cash flow, dividends, and book value-rather than traditional market capitalization weighting.
- USD strength pressures emerging market stock returns
- China dominates index weighting, driving concentrated country risk
- Fee competition from Vanguard and iShares pressures ETF margins
As of September 22, 2026, the stock is trading at USD 29.82 with a total of 92,205 shares traded. Over the past week, the price has changed by +1.75%, over one month by +2.65%, over three months by +4.32% and over the past year by +23.31%.
Current recommended Stop Loss: 29.40 (which is 1.4% or 1.4 ATR below the current price).
FTSE RAFI Emerging Markets has no consensus analysts rating.